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Supplementary figure 1: Characterization of hPSC-derived cardiomyocytes (NKX2-5 eGFP/w cell line). A) Relative gene expression levels of pluripotency markers (A) and cardiac markers (B). The mean Ct values of duplicate measurements were normalized against the values obtained for β actin for the same sample. After normalization, the means of three independent experiments were plotted. Data represent the mean ± SD. C) Immunostaining of hPSC-derived CMs with cTnT and SAA antibodies followed by counterstaining with DAPI. D) Flow cytometry analysis of cTnT and MLC2a expression. cTnT: cardiac Troponin T, MYH7: myosin heavy chain beta; SAA: sarcomeric actinin alpha, MLC2a: myosin light chain 2a. *p<0.05; **p<0.01; ****p<0.0001. Scale bar: 10 µm Clone 2
Supplementary figure 3: Analysis of the main potential off-target sites of Top2b CRISPR-Cas9. A) Potential off-target sites of Top2b-CRISPR gRNA1 (A1 to A4) and gRNA2 (B1 to B4). B) PCR amplification with primers specific to sequences A1 to B4. PCR products were purified and subjected to Sanger sequencing. 
